Apex Biotechnology Corp. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was TWD 521.95 million compared to TWD 576.39 million a year ago. Net income was TWD 45.59 million compared to TWD 34.16 million a year ago. Basic earnings per share was TWD 0.46 compared to TWD 0.34 a year ago. Diluted earnings per share was TWD 0.45 compared to TWD 0.31 a year ago.